Investing school

Learn investing basics with guides and articles written by Inderes' equity stock professionals.

Artikel2025-01-29 09:14 av

CSRD reporting from a stock picker’s perspective: Double materiality assessment

Double materiality assessment is a tricky term, but in practice it is the point in sustainability reporting where the most relevant issues for the stock picker should be identified.

What a stock picker should understand about the new mandatory corporate sustainability (CSRD) reports, part 1.

Artikel2025-01-21 11:24 av

Karoliina Loikkanen

What a stock picker should understand about the new mandatory corporate sustainability (CSRD) reports, part 1.

CSRD reports, or sustainability reports, will be part of mandatory annual reporting in the future. The reporting as a whole is very complex, and the aim of this new series of articles is to explain the key aspects of CSRD reporting for stock pickers.

Drug development investment: Value creation through M&As and licensing agreements

Artikel2024-12-19 11:07 av

Antti Siltanen

Drug development investment: Value creation through M&As and licensing agreements

The fourth part of our series of articles focusing on investing in Life Science companies deals with value creation in drug development companies through M&As and licensing agreements.

Faron Pharmaceuticals Herantis Pharma Orion Modulight

Välkommen med i Inderes community!

Skapa ett gratis användarkonto och försäkra dig om att inte missa några börsnyheter av intresse för precis dig!

FREE account

Stock market's most popular morning newsletter

Tillgång till analytikerkommentarer och rekommendationer

Vårt eget aktiescreeningsverktyg

PREMIUM account

Alla aktieanalyser och övrigt innehåll

Premiumverktyg (insidertransaktioner och aktiescreeningsverktyg)

Inderes modellportfölj

Skapa användarkonto

Probabilities of success in drug development

Artikel2024-09-26 13:26 av

Antti Siltanen

Probabilities of success in drug development

The second part of our series of articles focusing on the basics of investing in Life Science companies deals with the likelihood of successful drug development.

Faron Pharmaceuticals Herantis Pharma Mendus

Artikel2024-09-10 05:42 av

Antti Siltanen

Clinical phases of drug development

We are starting a series of articles focusing on the basics of investing in Life Science companies. This first part of the series describes the clinical phases of drug development that most drug development companies have to go through before they can apply for marketing authorization and commercialize a drug.

Faron Pharmaceuticals Herantis Pharma Orion Mendus

Artikel2025-01-14 09:29 av

Miika Purola, Kaisa Vanha-Perttula

Avkastning på kapital (ROE, ROI, ROIC, RONIC)

Att skapa aktieägarvärde är avgörande för alla börsbolags existens. Skapande av aktieägarvärde är därför en av de viktigaste uppgifterna för ett börsbolag.